SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001558370-24-003943
Filing Date
2024-03-26
Accepted
2024-03-26 16:05:45
Documents
118
Period of Report
2023-12-31

Document Format Files

Seq Description Document Type Size
1 10-K ganx-20231231x10k.htm   iXBRL 10-K 2486242
2 EX-4.1 ganx-20231231xex4d1.htm EX-4.1 47329
3 EX-23.1 ganx-20231231xex23d1.htm EX-23.1 6057
4 EX-31.1 ganx-20231231xex31d1.htm EX-31.1 10789
5 EX-31.2 ganx-20231231xex31d2.htm EX-31.2 10731
6 EX-32.1 ganx-20231231xex32d1.htm EX-32.1 10518
7 EX-97.1 ganx-20231231xex97d1.htm EX-97.1 39704
8 GRAPHIC ganx-20231231x10k001.jpg GRAPHIC 36401
9 GRAPHIC ganx-20231231x10k002.jpg GRAPHIC 47908
10 GRAPHIC ganx-20231231x10k003.jpg GRAPHIC 69003
11 GRAPHIC ganx-20231231x10k004.jpg GRAPHIC 32775
12 GRAPHIC ganx-20231231x10k005.jpg GRAPHIC 44747
13 GRAPHIC ganx-20231231x10k006.jpg GRAPHIC 45710
14 GRAPHIC ganx-20231231x10k007.jpg GRAPHIC 38088
  Complete submission text file 0001558370-24-003943.txt   12035177

Data Files

Seq Description Document Type Size
15 EX-101.SCH ganx-20231231.xsd EX-101.SCH 74101
16 EX-101.CAL ganx-20231231_cal.xml EX-101.CAL 75115
17 EX-101.DEF ganx-20231231_def.xml EX-101.DEF 267881
18 EX-101.LAB ganx-20231231_lab.xml EX-101.LAB 654587
19 EX-101.PRE ganx-20231231_pre.xml EX-101.PRE 520305
122 EXTRACTED XBRL INSTANCE DOCUMENT ganx-20231231x10k_htm.xml XML 2025567
Mailing Address 4800 HAMPDEN LANE SUITE 200 BETHESDA MD 20814
Business Address 4800 HAMPDEN LANE SUITE 200 BETHESDA MD 20814 (301) 500-1556
Gain Therapeutics, Inc. (Filer) CIK: 0001819411 (see all company filings)

IRS No.: 851726310 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-40237 | Film No.: 24783533
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)